Tendenze della Ricerca Medica

Le pubblicazioni più impattanti della settimana in 29 specialità, curate dall'IA

Ultimo aggiornamento: 28 lug 2026

Oncologia5 articoli

Impatto 1

Clinical features of systemic amyloidosis: a scoping review.

Pubblicato: 2026-07-28

Blood advances

Medical Digest Indicizzato: 2026-07-29

(Summary generation failed. Please refer to the original article.)

Leggi su PubMed
Impatto 1

Nitroalkenes exploit dependence on autophagy-lysosome pathway in PARPi-Resistant triple negative breast cancer.

Pubblicato: 2026-07-28

Cancer letters

Medical Digest Indicizzato: 2026-07-29

(Summary generation failed. Please refer to the original article.)

Leggi su PubMed
Impatto 3

GBP6 maintains mitochondrial bioenergetics to promote immune evasion from NK cells in cervical cancer.

Pubblicato: 2026-07-27

Cell reports

Medical Digest Indicizzato: 2026-07-29

This study identifies GBP6 as a mitochondrial factor associated with aggressive cervical cancer, enriched in high-risk tumors and correlating with poor clinical outcomes. GBP6 knockdown suppresses tumor cell proliferation and promotes cell death by disrupting mitochondrial bioenergetics and induc...

Leggi su PubMed
Impatto 3

Spatiotemporally Ultrasound-Controlled Nanoparticles Reprogramming Immunostimulatory Antigen-Presenting Cancer-Associated Fibroblasts to Enhance Cancer Immunotherapy.

Pubblicato: 2026-07-27

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Medical Digest Indicizzato: 2026-07-29

This study focuses on reprogramming myofibroblastic cancer-associated fibroblasts (CAFs) into immune activated antigen presenting CAFs (apCAFs) as a treatment for fibrotic breast cancer. Using a spatiotemporally ultrasound-controlled nanoparticle, the researchers successfully reprogrammed myCAFs ...

Leggi su PubMed
Impatto 3

Targeting TOMM40 unleashes immunogenic mitophagy to facilitate antigen presentation and immunotherapy sensitization.

Pubblicato: 2026-07-27

Journal for immunotherapy of cancer

Medical Digest Indicizzato: 2026-07-29

This study explores the role of mitophagy in cancer immunogenicity, identifying TOMM40 as a gatekeeper of mitochondrial import that restrains mitophagy. Loss of TOMM40 induces mitochondrial dysfunction and hyperactivated mitophagy, converting immune-cold tumors into immune-inflamed states with in...

Leggi su PubMed

Ricevi riassunti giornalieri personalizzati

Medici di tutto il mondo iniziano la giornata con revisioni della letteratura curate dall'IA, consegnate alle 7.

Prova gratuita di 14 giorni